Trial Profile
A Phase II/III Study to Assess the Safety and Immunogenicity of subcutaneous DNK-FLU in Healthy Japanese Children
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 01 Jun 2016
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Denka Seiken
- 01 Jun 2016 New trial record